Literature DB >> 102133

A comparison of tissue gold levels in guinea-pigs after treatment with myocrisin injected intramuscularly and triethylphosphine gold chloride and myocrisin administered orally.

H Kamel, D H Brown, J M Ottaway, W E Smith, J Cottney, A J Lewis.   

Abstract

A comparative study of tissue gold levels produced in guinea-pigs after the oral administration of either triethylphosphine gold chloride or Myocrisin (sodium aurothiomalate) or after the injection of Myocrisin intramuscularly is reported. Gold concentrations were determined 5, 24 and 168 hours after administration in stomach, small intestine, large intestine, kidney, liver and spleen and 5 and 24 hours after administration in skin, adrenals, heart, lung and brain. In gastrointestinal tissues, tissue gold concentrations were highest with triethylphosphine gold chloride. The stomach gold level 5 hours after oral administration of triethylphosphine gold chloride is particularly high and, taken in conjunction with the other gastrointestinal gold levels measured, suggests that a stomach rather than an intestinal absorption mechanism may predominate. A more extensive time-course study on kidney and liver is reported and the possible relationship between tissue concentration and toxicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102133     DOI: 10.1007/bf02111444

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  11 in total

1.  Distribution of sulfur-35- and gold-198-labeled gold thioglucose in mice.

Authors:  H A SWARTZ; J E CHRISTIAN; F N ANDREWS
Journal:  Am J Physiol       Date:  1960-07

2.  Distribution and excretion of radiogold in animals.

Authors:  M R JEFFREY; H F FREUNDLICH; D M BALLEY
Journal:  Ann Rheum Dis       Date:  1958-03       Impact factor: 19.103

3.  Determination of gold in tissue by carbon-furnace atomic-absorption spectrometry.

Authors:  H Kamel; D H Brown; J M Ottaway; W E Smith
Journal:  Talanta       Date:  1977-05       Impact factor: 6.057

4.  Determination of gold in blood fractions by atomic-absorption spectrometry using carbon rod and carbon furnace atomisation.

Authors:  H Kamel; D H Brown; J M Ottaway; W E Smith
Journal:  Analyst       Date:  1976-10       Impact factor: 4.616

5.  Antiarthritic properties and unique pharmacologic profile of a potential chrysotherapeutic agent: S K & F D-30162.

Authors:  D T Walz; M J DiMartino; L W Chakrin; B M Sutton; A MISHER
Journal:  J Pharmacol Exp Ther       Date:  1976-04       Impact factor: 4.030

6.  Determination of gold in separate protein fractions of blood serum by carbon furnace atomic-absorption spectrometry.

Authors:  H Kamel; D H Brown; J M Ottaway; W E Smith
Journal:  Analyst       Date:  1977-09       Impact factor: 4.616

7.  Tissue gold concentration in a rheumatoid arthritic receiving chrysotherapy.

Authors:  N L Gottlieb; P M Smith; E M Smith
Journal:  Arthritis Rheum       Date:  1972 Jan-Feb

8.  Transport of gold in the body.

Authors:  E G McQueen; P W Dykes
Journal:  Ann Rheum Dis       Date:  1969-07       Impact factor: 19.103

9.  Gold levels in kidney, liver, and spleen.

Authors:  H Kamel; D H Brown; J M Ottaway; W E Smith; W H Auld; N E Cunningham
Journal:  Arthritis Rheum       Date:  1976 Nov-Dec

10.  Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors:  A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal:  Ann Rheum Dis       Date:  1976-06       Impact factor: 19.103

View more
  2 in total

Review 1.  Gold-based therapy: From past to present.

Authors:  Alice Balfourier; Jelena Kolosnjaj-Tabi; Nathalie Luciani; Florent Carn; Florence Gazeau
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-08       Impact factor: 11.205

2.  Action of gold salts in some inflammatory and immunological models.

Authors:  A J Lewis; J Cottney; D D White; P K Fox; A McNeillie; J Dunlop; W E Smith; D H Brown
Journal:  Agents Actions       Date:  1980-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.